Concepedia

Maciej Czarnecki

MC

Statistics

Publications

4

Citations

3.2K

H-Index

4

Active since

2018

Affiliations

Alector (United States)(Current)

Maciej Czarnecki is an author at Alector (United States) specializing in neurology, neurodegenerative diseases, and alzheimer disease.

ORCID

Publications per year

2018–2023

4

Publications

4

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text

, , +17

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 337 citations · Full text

, , +14

Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease

Edmond Teng, Paul T. Manser, Karen Pickthorn et al. · JAMA Neurology · 2022 · 191 citations · Full text

, , +17

Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet

Cecília Monteiro, Balázs István Tóth, Flávia Brunstein et al. · Neurology · 2023 · 108 citations · Full text

, , +17

1–4 of 4